The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Pieter Stella
Showing 1-20 of 22 articles
Coronary sinus narrowing for the treatment of refractory angina: a multicentre prospective open-label clinical study (the REDUCER-I study)
Verheye S,
Agostoni P,
Giannini F,
Hill J,
Jensen C,
Lindsay S,
Stella P,
Redwood S,
Banai S,
Konigstein M
September 20, 2021 | 10.4244/EIJ-D-20-00873
A pilot study with the TriGUARD 3 cerebral embolic protection device
Magalhaes P,
Kooistra N,
Leenders G,
Margolis P,
Lansky AJ,
Kraaijeveld A,
Voskuil M,
Stella P
August 7, 2020 | 10.4244/EIJ-D-19-00741
Coronary artery treatment with a urea-based paclitaxel-coated balloon: the European-wide FALCON all-comers DCB Registry (FALCON Registry)
Widder J,
Cortese B,
Levesque S,
Berliner D,
Eccleshall S,
Graf K,
Doutrelant L,
Ahmed J,
Bressollette E,
Zavalloni D,
Piraino D,
Roguin A,
Scheller B,
Stella P,
Bauersachs J
July 19, 2019 | 10.4244/EIJ-D-18-00261
Intracardiac shunts following transcatheter aortic valve implantation: a multicentre study
Amat-Santos I,
Rojas P,
Stella P,
Nombela-Franco L,
Burgui R,
Muñoz-García A,
Serra V,
Gutierrez-Ibanes E,
Larman M,
Olivares R,
Kooistra N,
Gutierrez H,
San Roman J
April 20, 2018 | 10.4244/EIJ-D-17-00737
An unexpected huge coronary aneurysm
Chan Y,
Duckers E,
Stella P
October 20, 2016 | 10.4244/EIJV12I9A190
Direct implantation of rapamycin-eluting stents with bioresorbable drug carrier technology utilising the Svelte coronary stent-on-a-wire: the DIRECT II study
Verheye S,
Khattab A,
Carrié D,
Stella P,
Slagboom T,
Bartunek J,
Onuma Y,
Serruys P
August 5, 2016 | 10.4244/EIJV12I5A101
Evaluation of a crystalline sirolimus-eluting coronary stent with a bioabsorbable polymer designed for rapid dissolution: two-year outcomes from the DESSOLVE I and II trials
Wijns W,
Suttorp MJ,
Zagozdzon L,
Morice M,
McClean D,
Stella P,
Donohoe D,
Knape C,
Ormiston J
June 20, 2016 | 10.4244/EIJY15M09_14
Clinical results with the Resolute zotarolimus-eluting stent in total coronary occlusions
Kelbæk H,
Holmvang L,
Richardt G,
Eberli F,
Stella P,
Buszman P,
Neumann F,
Serruys P,
Windecker S,
Widimský P,
Belardi J,
Silber S
October 20, 2015 | 10.4244/EIJY14M07_14
Optimisation of transcatheter aortic balloon-expandable valve deployment: the two-step inflation technique
Nijhoff F,
Agostoni P,
Samim M,
Ramjankhan F,
Kluin J,
Doevendans P,
Stella P
September 27, 2013 | 10.4244/EIJV9I5A91
Six-month and one-year clinical outcomes after placement of a dedicated coronary bifurcation stent: a patient-level pooled analysis of eight registry studies
Grundeken M.J,
Asgedom S,
Damman P,
Lesiak M,
Norell M,
Garcia E,
Bethencourt A,
Woudstra P,
Koch K,
Vis M,
Henriques J,
Onuma Y,
Foley DP,
Bartorelli A,
Stella P,
Thijssen J,
de Winter R,
Wykrzykowska J
June 28, 2013 | 10.4244/EIJV9I2A34
Clinical and angiographic outcomes following first-in-man implantation of a novel thin-strut low-profile fixed-wire stent: the Svelte Coronary Stent Integrated Delivery System first-in-man trial
Diletti R,
Garcia-Garcia H,
Bourantas C,
van Geuns R,
Van Mieghem N,
Agostoni P,
Muramatsu T,
Farooq V,
Spencer R,
de Schepper J,
Pomeranz M,
Stella P,
Serruys P
May 21, 2013 | 10.4244/EIJV9I1A18
Percutaneous intervention of saphenous vein graft lesions
Agostoni P,
Voskuil M,
Onsea K,
Vermeersch P,
Stella P
May 17, 2013
First-in-man experience with a new embolic deflection device in transcatheter aortic valve interventions
Onsea K,
Agostoni P,
Samim M,
Voskuil M,
Kluin J,
Budde R,
Hendrikse J,
Ramjankhan F,
van Klarenbosch J,
Doesburg P,
Sieswerda G,
Stella P
May 15, 2012 | 10.4244/EIJV8I1A9
Why the provisional single-stent approach is not always the right strategy; arguments for the development of dedicated bifurcation devices
Grundeken M.J,
Stella P,
Wykrzykowska J
March 21, 2012 | 10.4244/EIJV7I11A199
A prospective multicentre registry, evaluating real-world usage of the Tryton side branch stent: results of the E-Tryton 150/Benelux registry
Agostoni P,
Foley DP,
Lesiak M,
Belkacemi A,
Dens J,
Kumsars I,
Scott B,
Oemrawsingh P,
Dubois C,
Garcia E,
Lefèvre T,
Stella P
March 21, 2012 | 10.4244/EIJV7I11A204
Tools & Techniques: Percutaneous intervention of saphenous vein graft lesions
Agostoni P,
Voskuil M,
Onsea K,
Vermeersch P,
Stella P
November 30, 2011 | 10.4244/EIJV7I8A136
The Valentines Trial: results of the first one week worldwide multicentre enrolment trial, evaluating the real world usage of the second generation DIOR paclitaxel drug-eluting balloon for in-stent restenosis treatment
Stella P,
Belkacemi A,
Waksman R,
Stahnke S,
Torguson R,
Von Strandmann R,
Agostoni P,
Sangiorgi G,
Silber S
October 28, 2011 | 10.4244/EIJV7I6A113
Coronary bifurcation lesions treated with the drug-eluting balloon: a preliminary insight from the DEBIUT study
Belkacemi A,
Agostoni P,
Voskuil M,
Stella P
May 17, 2011
Drug-eluting balloons and bifurcations, a new future?
Stella P,
Belkacemi A,
Agostoni P
January 11, 2011
One year results of a new in situ length-adjustable stent platform with a biodegradable Biolimus A9 eluting polymer: results of the CUSTOM-II trial
Stella P,
Mueller R,
Pavlakis G,
De Bruyne B,
Hauptmann K-E,
Morice M,
Chevalier B,
Fajadet J,
Sievert H,
Grube E
August 20, 2008
1
2
Latest news
NEW ISSUE
A TAVI in Bicuspid Anatomies; TMVI; Bailout-TEER or Medical Therapy; DRT following LAAO; Cost-Effectiveness of FFR-Guided MVD Revascularisation in STEMI and more
June 24, 2022
AHEAD OF PRINT
Bioprosthetic dysfunction of the LOTUS valve
FREE ARTICLE - Rutger-Jan Nuis et al
June 17, 2022
AHEAD OF PRINT
Coronary access after ViV-TAVI with ACURATE neo2
FREE ARTICLE - Arif A. Khokhar et al.
June 16, 2022
AHEAD OF PRINT
Prognostic value of structural and functional microvascular dysfunction
FREE ARTICLE - Coen K.M. Boerhout et al
June 13, 2022
AHEAD OF PRINT
TAVR with the ACURATE neo2
FREE ARTICLE - Andrea Scotti et al
June 8, 2022
AHEAD OF PRINT
Antithrombotic strategy selection using smartphone technology
FREE ARTICLE - Jaya Chandrasekhar et al
June 3, 2022
AHEAD OF PRINT
The fingerprints of plaque rupture healing as detected by serial OCT imaging
FREE ARTICLE - Rocco Vergallo et al
June 2, 2022
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke